These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
579 related items for PubMed ID: 23183268
1. miR-1290 and its potential targets are associated with characteristics of estrogen receptor α-positive breast cancer. Endo Y, Toyama T, Takahashi S, Yoshimoto N, Iwasa M, Asano T, Fujii Y, Yamashita H. Endocr Relat Cancer; 2013 Feb; 20(1):91-102. PubMed ID: 23183268 [Abstract] [Full Text] [Related]
2. Immunohistochemical determination of the miR-1290 target arylamine N-acetyltransferase 1 (NAT1) as a prognostic biomarker in breast cancer. Endo Y, Yamashita H, Takahashi S, Sato S, Yoshimoto N, Asano T, Hato Y, Dong Y, Fujii Y, Toyama T. BMC Cancer; 2014 Dec 20; 14():990. PubMed ID: 25528056 [Abstract] [Full Text] [Related]
3. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines. Wu Q, Guo L, Jiang F, Li L, Li Z, Chen F. J Cell Mol Med; 2015 Dec 20; 19(12):2874-87. PubMed ID: 26416600 [Abstract] [Full Text] [Related]
4. Effects of differential distribution of microvessel density, possibly regulated by miR-374a, on breast cancer prognosis. Li JY, Zhang Y, Zhang WH, Jia S, Kang Y, Tian R. Asian Pac J Cancer Prev; 2013 Dec 20; 14(3):1715-20. PubMed ID: 23679262 [Abstract] [Full Text] [Related]
5. MiR-190b, the highest up-regulated miRNA in ERα-positive compared to ERα-negative breast tumors, a new biomarker in breast cancers? Cizeron-Clairac G, Lallemand F, Vacher S, Lidereau R, Bieche I, Callens C. BMC Cancer; 2015 Jul 05; 15():499. PubMed ID: 26141719 [Abstract] [Full Text] [Related]
9. Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker. Johansson I, Nilsson C, Berglund P, Lauss M, Ringnér M, Olsson H, Luts L, Sim E, Thorstensson S, Fjällskog ML, Hedenfalk I. Breast Cancer Res; 2012 Feb 14; 14(1):R31. PubMed ID: 22333393 [Abstract] [Full Text] [Related]
11. VGLL1 expression is associated with a triple-negative basal-like phenotype in breast cancer. Castilla MÁ, López-García MÁ, Atienza MR, Rosa-Rosa JM, Díaz-Martín J, Pecero ML, Vieites B, Romero-Pérez L, Benítez J, Calcabrini A, Palacios J. Endocr Relat Cancer; 2014 Aug 14; 21(4):587-99. PubMed ID: 24891455 [Abstract] [Full Text] [Related]
12. Distinct expressions of microRNAs that directly target estrogen receptor α in human breast cancer. Yoshimoto N, Toyama T, Takahashi S, Sugiura H, Endo Y, Iwasa M, Fujii Y, Yamashita H. Breast Cancer Res Treat; 2011 Nov 14; 130(1):331-9. PubMed ID: 21755340 [Abstract] [Full Text] [Related]
13. MiR-4728-3p could act as a marker of HER2 status. Li H, Zhou X, Zhu J, Cheng W, Zhu W, Shu Y, Liu P. Cancer Biomark; 2015 Nov 14; 15(6):807-14. PubMed ID: 26406406 [Abstract] [Full Text] [Related]
14. Gene expression analysis of invasive breast carcinoma yields differential patterns in luminal subtypes of breast cancer. Abdelhafiz AS, Fouda MA, Elzefzafy NA, Taha II, Mohemmed OM, Alieldin NH, Toony I, Abdel Wahab AA, Farahat IG. Ann Diagn Pathol; 2021 Dec 14; 55():151814. PubMed ID: 34517157 [Abstract] [Full Text] [Related]
17. CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis. Ramezani F, Salami S, Omrani MD, Maleki D. Asian Pac J Cancer Prev; 2012 Dec 14; 13(2):451-7. PubMed ID: 22524805 [Abstract] [Full Text] [Related]
18. The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer. Liu SS, Li Y, Zhang H, Zhang D, Zhang XB, Wang X, Yu Y. Theranostics; 2020 Dec 14; 10(23):10729-10742. PubMed ID: 32929377 [Abstract] [Full Text] [Related]
19. RNA helicase DDX5 regulates microRNA expression and contributes to cytoskeletal reorganization in basal breast cancer cells. Wang D, Huang J, Hu Z. Mol Cell Proteomics; 2012 Feb 14; 11(2):M111.011932. PubMed ID: 22086602 [Abstract] [Full Text] [Related]
20. Expression of KAI1/CD82 in distant metastases from estrogen receptor-negative breast cancer. Christgen M, Christgen H, Heil C, Krech T, Länger F, Kreipe H, Lehmann U. Cancer Sci; 2009 Sep 14; 100(9):1767-71. PubMed ID: 19549254 [Abstract] [Full Text] [Related] Page: [Next] [New Search]